ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

PNIH Says New Env. Care Study Section On The Way

February 3, 1978

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

September 13, 2013